GenVec Company Profile (NASDAQ:GNVC)

About GenVec

GenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: GNVC
CUSIP:

Key Metrics:

Previous Close: $0.50
50 Day Moving Average: $0.5786
200 Day Moving Average: $0.6579
52-Week Range: $0.35 - $3.69
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.79
P/E Growth: -0.0500
Market Cap: $11.42M
Outstanding Shares: 22,736,000
Beta: 2.22

Profitability:

Net Margins: -927.05%
Return on Equity: -83.14%
Return on Assets: -64.49%

Debt:

Current Ratio: 7.28%
Quick Ratio: 7.28%

Additional Links:

Companies Related to GenVec:

Consensus Ratings for GenVec (NASDAQ:GNVC) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$3.10 (516.92% upside)

Analysts' Ratings History for GenVec (NASDAQ:GNVC)

Show:

Date	Firm	Action	Rating	Price Target
7/26/2016	Roth Capital	Reiterated Rating	Buy	$8.00 -> $2.00
6/20/2016	Rodman & Renshaw	Reiterated Rating	Buy	$2.30
5/3/2016	HC Wainwright	Reiterated Rating	Buy

(Data available from 9/25/2014 forward)

Earnings History for GenVec (NASDAQ:GNVC)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/7/2016
8/5/2016	Q116	($0.10)	($0.06)			View	N/A
5/12/2016		($0.09)	($0.11)			View	N/A
3/9/2016	Q415	($0.08)	($0.10)			View	N/A
8/7/2015	Q215	($0.10)	($0.11)			View	N/A
5/8/2015	Q115	($0.06)	($0.09)			View	N/A
3/24/2015	Q414	$0.08	$0.11	$3.33 million	$3.50 million	View	Listen
11/12/2014	Q314	($0.11)	($0.10)			View	N/A
8/12/2014	Q214	($0.15)	($0.10)			View	N/A
5/12/2014	Q114	$0.04	($0.07)	$2.00 million	$2.10 million	View	N/A
3/28/2014	Q413	($0.16)	($0.07)	$1.52 million	$0.15 million	View	Listen
11/12/2013	Q313		($0.23)	$2.10 million	$1.60 million	View	N/A
11/9/2012	Q312	($0.32)	($0.30)	$2.90 million	$2.13 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for GenVec (NASDAQ:GNVC)

Current Year EPS Consensus Estimate: $-0.29 EPS
Next Year EPS Consensus Estimate: $-0.28 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2016	1	($0.09)	($0.09)	($0.09)
Q3 2016	1	($0.09)	($0.09)	($0.09)
Q4 2016	1	($0.09)	($0.09)	($0.09)

(Data provided by Zacks Investment Research)

Dividend History for GenVec (NASDAQ:GNVC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for GenVec (NASDAQ:GNVC)

Insider Ownership Percentage: 8.10%
Institutional Ownership Percentage: 26.79%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/16/2016	Douglas J Swirsky	CEO	Buy	10,000	$0.50	$5,000.00
12/14/2015	Douglas J Swirsky	CEO	Buy	5,000	$2.00	$10,000.00
11/16/2015	Stefan Loren	Director	Buy	4,000	$1.93	$7,720.00
8/11/2015	Douglas E Brough	Insider	Buy	4,600	$2.34	$10,764.00
5/27/2014	Ecor1 Capital, Llc	Major Shareholder	Buy	24,140	$2.24	$54,073.60
3/28/2014	Ecor1 Capital, Llc	Major Shareholder	Buy	122,273	$2.55	$311,796.15

(Data available from 1/1/2013 forward)

Latest Headlines for GenVec (NASDAQ:GNVC)

Date	Headline
	Keen Investors Find News on GenVec, Inc. (NASDAQ:GNVC) - Duncan Research (NASDAQ:GNVC) www.duncanindependent.com - September 24 at 4:57 PM
	Penny Stock Investors Take an Interest in GenVec, Inc. (NASDAQ:GNVC) - Duncan Research (NASDAQ:GNVC) www.duncanindependent.com - September 21 at 9:30 AM
	GENVEC INC Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:GNVC) biz.yahoo.com - September 1 at 8:10 AM
	GenVec, Inc. (NASDAQ:GNVC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - August 26 at 8:15 AM
	GenVec faces delisting threat after it fails to raise share price (NASDAQ:GNVC) www.bizjournals.com - August 25 at 5:18 PM
	GENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf (NASDAQ:GNVC) biz.yahoo.com - August 24 at 8:18 AM
	Shares Spotted Gapping Up Pre-Bell: GenVec, Inc. (NASDAQ:GNVC) - Post News (NASDAQ:GNVC) www.kentuckypostnews.com - August 19 at 8:12 AM
	Will GenVec, Inc. (NASDAQ:GNVC) Hit $2.3 Price Target? - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - August 19 at 8:12 AM
	Stock Update on GenVec, Inc. (NASDAQ:GNVC) - Duncan Research (NASDAQ:GNVC) www.duncanindependent.com - August 12 at 8:21 AM
	GenVec, Inc. :GNVC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:GNVC) www.capitalcube.com - August 9 at 4:03 PM
	GenVec Inc.: GenVec Reports Second Quarter 2016 Financial Results (NASDAQ:GNVC) www.twst.com - August 5 at 5:25 PM
	GenVec Reports Second Quarter 2016 Financial Results (NASDAQ:GNVC) www.publicnow.com - August 5 at 8:12 AM
	Can Shares Of GenVec, Inc. (NASDAQ:GNVC) Hit $2.3? - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - July 29 at 12:25 PM
	Biotech news that matter for investors: GenVec (NASDAQ:GNVC), Achillion Pharmaceuticals (NASDAQ:ACHN) - The Voice Registrar (NASDAQ:GNVC) voiceregistrar.com - July 27 at 8:01 AM
	Volatile Measures on Top- GenVec, Inc. (NASDAQ:GNVC), AerCap Holdings (NYSE:AER), First Data Corporation ... - Seneca Globe (NASDAQ:GNVC) www.senecaglobe.com - July 27 at 8:01 AM
	GenVec (GNVC) Says FDA Clinical Hold on CGF166 Phase 1/2 Lifted (NASDAQ:GNVC) www.streetinsider.com - July 25 at 5:20 PM
	Is $8 Price Target Attainable For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - July 22 at 8:10 AM
	Genvec Incorporated (NASDAQ:GNVC) Sellers Increased By 26.75% Their Shorts - Consumer Eagle (NASDAQ:GNVC) www.consumereagle.com - July 20 at 6:40 PM
	Genvec Incorporated (NASDAQ:GNVC) Shorted Shares Decreased By 1.99% - Press Telegraph (NASDAQ:GNVC) presstelegraph.com - July 15 at 8:18 AM
	Strong Sell Calls For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - July 15 at 8:18 AM
	Watching Unusual Volume on Shares of: GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily (NASDAQ:GNVC) www.engelwooddaily.com - July 12 at 5:32 PM
	Is $8 Within Reach For GenVec, Inc. (NASDAQ:GNVC)? - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - July 8 at 8:07 AM
	Broker Outlook For GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) www.fiscalstandard.com - July 7 at 8:05 AM
	Company Stock Lower on the Week GenVec, Inc. (NASDAQ:GNVC) - Engelwood Daily (NASDAQ:GNVC) www.engelwooddaily.com - July 4 at 4:55 PM
	Broker Outlook For The Week Ahead GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) www.fiscalstandard.com - July 4 at 4:55 PM
	Genvec Incorporated (NASDAQ:GNVC) Shorts Decreased by 1.99% After Short Covering - Engelwood Daily (NASDAQ:GNVC) www.engelwooddaily.com - July 2 at 8:11 AM
	GenVec, Inc. (NASDAQ:GNVC) Expected to Reach Highs Of $8 - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - July 1 at 8:02 AM
	GenVec, Inc. (GNVC) Updated Price Targets - FTSE News (NASDAQ:GNVC) www.ftsenews.co.uk - June 30 at 8:05 AM
	Next Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Fiscal Standard (NASDAQ:GNVC) www.fiscalstandard.com - June 27 at 5:12 PM
	Brokers Issue Average Price Target Of 5.10 On GenVec, Inc. (GNVC) - FTSE News (NASDAQ:GNVC) www.ftsenews.co.uk - June 23 at 4:28 PM
	Strong Sell Calls Recommendations For GenVec, Inc. (NASDAQ:GNVC) At 0 - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - June 23 at 4:28 PM
	GenVec, Inc. (GNVC) Current Analyst Ratings - Fiscal Standard (NASDAQ:GNVC) www.fiscalstandard.com - June 22 at 5:23 PM
	GenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw (NASDAQ:GNVC) breakingfinancenews.com - June 22 at 9:54 AM
	GenVec Inc (NASDAQ:GNVC) target price bumped up to $2 as issued in a report today by Rodman & Renshaw - Breaking Finance News (NASDAQ:GNVC) breakingfinancenews.com - June 21 at 5:00 PM
	GenVec, Inc. (GNVC) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:GNVC) www.fiscalstandard.com - June 19 at 4:56 PM
	Strong Buy Calls Count For GenVec, Inc. (NASDAQ:GNVC) At 1 - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - June 16 at 5:18 PM
	GENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (NASDAQ:GNVC) biz.yahoo.com - June 2 at 11:22 AM
	Insiders Are Gradually Buying GenVec, Inc. (NASDAQ:GNVC) - HNN (NASDAQ:GNVC) hintsnewsnetwork.com - June 2 at 5:11 AM
	Performance at a Glance on GenVec, Inc. (NASDAQ:GNVC) - HNN (NASDAQ:GNVC) hintsnewsnetwork.com - May 29 at 7:27 PM
	GenVec, Inc. (NASDAQ:GNVC) Impact Score At 0 - Investor Newswire (NASDAQ:GNVC) www.investornewswire.com - May 29 at 7:27 PM
	New Broker Ratings For GenVec, Inc. (GNVC) - FTSE News (NASDAQ:GNVC) www.ftsenews.co.uk - May 23 at 12:43 PM
	After Last Week What Do Analysts Think Of GenVec, Inc. (GNVC) - Share Trading News (NASDAQ:GNVC) www.sharetrading.news - May 22 at 6:59 PM
	Revenue Update on GenVec Inc(NASDAQ:GNVC) - Trade Calls (NASDAQ:GNVC) www.tradecalls.org - May 21 at 12:39 AM
	GenVec, Inc. :GNVC-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:GNVC) www.capitalcube.com - May 17 at 12:49 PM
	GenVec, Inc. (NASDAQ:GNVC) One-Year Mean Price Target At $6.5 - Stocks Daily (NASDAQ:GNVC) www.stocksdaily.net - May 16 at 7:16 PM
	GenVec Reports First Quarter 2016 Financial Results (NASDAQ:GNVC) www.publicnow.com - May 12 at 8:17 AM
	GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Fi (NASDAQ:GNVC) biz.yahoo.com - May 10 at 5:48 PM
	GenVec, Inc. (NASDAQ:GNVC) ABR Of 1 - Stocks Daily (NASDAQ:GNVC) www.stocksdaily.net - May 9 at 1:18 AM
	Next Weeks Broker Price Targets For GenVec, Inc. (GNVC) - Share Trading News (NASDAQ:GNVC) www.sharetrading.news - May 9 at 1:18 AM
	GENVEC INC Financials (NASDAQ:GNVC) finance.yahoo.com - March 12 at 1:04 PM